Dermal Filler Market is Expected to Generate $14.4 Billion by 2031, Claims Allied Market Research
The global dermal filler market is expanding rapidly due to a surge in prevalence of skin aging, rise in demand for dermal fillers and minimal invasive surgical procedures, increase in geriatric population and rise in self-awareness across young population related to physical appearance. On the basis of region, Asia-Pacific is estimated to witness a noteworthy growth by 2031.
Wilmington, Delaware, Oct. 23, 2023 (GLOBE NEWSWIRE) — The report published by Allied Market Research on the global dermal fillers market indicates that the industry was valued at $5.1 billion in 2021 and is expected to generate $14.4 billion at the end of 2031, with 10.8% CAGR from the year 2022 to 2031. The report provides an in-depth examination of evolving market trends, primary market segments, significant areas for investment, the value chain, regional overview, and the competitive situation. It serves as a valuable source of information for both established market leaders and newcomers, as well as for investors and stakeholders seeking to formulate future strategies and enhance their market position.
Request Sample of the Report on Dermal Filler Market Forecast 2032 – https://www.alliedmarketresearch.com/request-sample/7654
Report coverage & details:
|Market Size in 2031||$14.4 billion|
|No. of Pages in Report||250|
|Drivers||Rise in prevalence of early skin aging|
|Surge in demand for minimal invasive surgical procedure|
|Increase in demand for dermal fillers procedures|
|Rise in geriatric population|
|Increase in self-awareness among young population regarding physical appearance|
|Opportunities||Technological advancement in medical aesthetic products
Surge in healthcare expenditure
|Restraints||High costs associated with dermal filler procedures such as fat face and polymethyl-methacrylate microspheres|
Recent Developments in the Dermal Filler Market
- In February 2022, AbbVie Inc., a global leader in the pharmaceutical industry received the Food and Drug Administration (FDA) approval for JUVEDERM VOLBELLA XC, which is the first dermal filler used for the treatment of infraorbital hollows in adults over 21 years old. This approval will help the company to expand its Aesthetics product portfolio.
- In February 2022, Merz Aesthetics, a global medical aesthetics company has launched its Radiesse Lidocaine injectable implant for soft tissue augmentation. It aims to improve moderate to severe loss of jawline contour in adults.
- In February 2021, Galderma, a pharmaceutical manufacturing company received the U.S. Food and Drug Administration (FDA) approval for its Restylane Defyne to augment and correct mild to moderate chin retrusion.
- In October 2020, AbbVie Inc., a global pharmaceutical company acquired the Luminera, a privately held, aesthetics company to enhance the international dermal filler portfolio, with its JUVEDERM collection of fillers. This Acquisition will help the company to gain strong Foothold in dermal fillers market.
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/7654
The report provides an in-depth segmentation of the global dermal filler market on the basis of gender, service provider, type, and region. The report conducts an analysis of every segment and its sub-segments, utilizing visual aids such as tables and figures. This analysis is a valuable resource for market participants, investors, and those entering the market, assisting them in identifying the specific sub-segments that offer growth opportunities in the forthcoming years.
By type, the hyaluronic acid (HA) segment contributed to more than two-thirds of the global dermal filler market revenue in 2021 and is estimated to maintain its dominance throughout the forecast timeframe. Also, the same segment would cite a noteworthy CAGR of 11.1% from 2022 to 2031. The report also analyses the poly l lactic acid, calcium hydroxylapatite, and others segments.
When it’s come to gender category, the female segment accounted more than 90% of the market share in 2021 and estimated to lead the trail throughout the forecast timeframe. The same segment is expected to portray a notable CAGR of 10.8% during the forecast year. The male segment is also analyzed in the report.
Under the service provider category, the hospital segment grabbed the lion’s share in 2021 accounting for more than two-fifths of the overall market revenue and is estimated to retain its dominance by 2031. The same segment would display the highest CAGR of 11.1% during the forecast period.
For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/7654
The regional analysis in the report concludes that the North America region garnered the major share in 2021 accounting for nearly two-fifths of the global market and will lead the trail throughout the forecast timeframe. On the other hand, the market across Asia-Pacific is estimated to experience substantial growth with 11.8% CAGR during the forecast period. The other regions analyzed in the report are LAMEA and Europe.
Top players profiled in the global dermal fillers market are Vital Esthetique Laboratories, Teoxane Laboratories, Sinclair Pharma, Revance Therapeutics, MerzPharma GmbH and Co. KGaA, Galderma SA, Elan Aesthetics Inc., Bioxis Pharmaceutical, Cutera Inc., and AbbVie Laboratories.
The report offers an in-depth analysis of the major players in the global dermal filler market. These companies have employed a variety of strategies, including expansion, the introduction of new products, partnerships, and other initiatives, to enhance their market presence and strengthen their position within the industry. The report is a valuable resource for evaluating the operational segments, product offerings, business performance, and innovations undertaken by each market player.
Comprehensive Healthcare Industry Research Studies: –
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.